Physician profile
Darshan Patel
NPI 1295977809
$1,876.08
in general payments reported to CMS, 2019-2025
15 companies · $1,327 in 2025
The $1,327 reported for 2025 was more than what 89% of Child & Adolescent Psychiatry providers received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.72 · 2020: $17.02 · 2021: $105 · 2022: $119 · 2023: $272 · 2025: $1,327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,199 · Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,199.45 |
| Food and Beverage | $400.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,274.95 | 2025 | Proclaim, Eterna |
| Janssen Pharmaceuticals, INC | $149.28 | 2022-2025 | Spravato, Invega Trinza, Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $57.10 | 2022-2023 | Rexulti, Abilify Maintena |
| Supernus Pharmaceuticals, INC. | $54.97 | 2023 | Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.13 | 2021-2022 | |
| Glaxosmithkline, LLC. | $51.53 | 2019-2021 | |
| Corium, LLC | $43.09 | 2022-2023 | Azstarys |
| Sunovion Pharmaceuticals INC. | $41.66 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.19 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $25.92 | 2023 | Austedo |
| La Jolla Pharmaceutical Company | $25.09 | 2025 | |
| Lundbeck LLC | $22.44 | 2023 | Rexulti |
| Alkermes, INC. | $19.26 | 2023 | Aristada, Lybalvi |
| Arbor Pharmaceuticals, INC. | $15.93 | 2021 | |
| Brainsway USA INC | $11.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darshan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.